Related Experiment Video
Updated: Jun 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
IgG Glycosylation-Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis
Rohit Upadhyay1, Alexia Orellana1, George C Tsokos2
1John W. Deming Department of Medicine, Section of Nephrology & Hypertension, Tulane University School of Medicine, New Orleans, Louisiana.
Abnormal IgG glycosylation in lupus nephritis (LN) activates CLEC7A and SYK in podocytes, causing kidney injury. Targeting this lectin-glycan-CLEC7A-SYK axis offers a new therapeutic strategy for LN patients.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE).
- Abnormal immunoglobulin G (IgG) glycosylation in LN patients contributes to podocyte injury.
- CLEC7A (C-type lectin domain family 7 member A) recognizes fucose on IgG, implicating lectin-glycan interactions in LN pathogenesis.
Purpose of the Study:
- To investigate the role of lectin-glycan interactions in LN-related podocyte dysfunction.
- To elucidate the CLEC7A-SYK pathway in LN-induced podocyte injury.
- To identify potential therapeutic targets for LN.
Main Methods:
- Assessed human podocyte responses to LN-IgG and CLEC7A ligand curdlan using qPCR, western blotting, and functional assays.
- Examined human kidney biopsies and MRL/lpr mouse kidneys for CLEC7A-SYK pathway activation.
- Investigated the effect of deglycosylation, CLEC7A silencing, and SYK inhibition on podocyte function.
Main Results:
- LN-IgG and curdlan increased podocyte CLEC7A expression, impaired motility, disrupted cytoskeleton, and reduced nephrin expression.
- Deglycosylation of LN-IgG prevented CLEC7A binding and preserved podocyte function.
- LN-IgG and curdlan activated calcium flux and the SYK pathway; CLEC7A and SYK were upregulated in LN kidney samples and MRL/lpr mice; SYK inhibition or CLEC7A silencing protected podocytes.
Conclusions:
- A novel IgG lectin-glycan-CLEC7A-SYK axis is involved in LN pathogenesis.
- This pathway mediates LN-related podocyte injury.
- Targeting the CLEC7A-SYK axis presents a potential therapeutic strategy for LN.
Related Concept Videos
Proteoglycans
Nephrotic Syndrome I : Introduction
Diabetic Nephropathy
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Lysosomal Hydrolases
The JAK-STAT Signaling Pathway